ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Injection Flu Vaccine Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-2W10868
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Injection Flu Vaccine Market Research Report 2022
BUY CHAPTERS

Global Human Injection Flu Vaccine Market Research Report 2025

Code: QYRE-Auto-2W10868
Report
February 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
CSL Limited
GSK
Viatris
Astrazeneca plc
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics

Human Injection Flu Vaccine Market Size

The global market for Human Injection Flu Vaccine was valued at US$ 8434 million in the year 2024 and is projected to reach a revised size of US$ 12050 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Human Injection Flu Vaccine Market

Human Injection Flu Vaccine Market

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Injection Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Injection Flu Vaccine.
The Human Injection Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Injection Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Injection Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Injection Flu Vaccine Market Report

Report Metric Details
Report Name Human Injection Flu Vaccine Market
Accounted market size in year US$ 8434 million
Forecasted market size in 2031 US$ 12050 million
CAGR 5.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • 6 Months to 3 Years
  • > 3 Years
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, Jiangsu GDK, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Injection Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Injection Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Human Injection Flu Vaccine Market growing?

Ans: The Human Injection Flu Vaccine Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Human Injection Flu Vaccine Market size in 2031?

Ans: The Human Injection Flu Vaccine Market size in 2031 will be US$ 12050 million.

Who are the main players in the Human Injection Flu Vaccine Market report?

Ans: The main players in the Human Injection Flu Vaccine Market are Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, Jiangsu GDK, KM Biologics

What are the Application segmentation covered in the Human Injection Flu Vaccine Market report?

Ans: The Applications covered in the Human Injection Flu Vaccine Market report are 6 Months to 3 Years, > 3 Years

What are the Type segmentation covered in the Human Injection Flu Vaccine Market report?

Ans: The Types covered in the Human Injection Flu Vaccine Market report are Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine

Recommended Reports

Influenza Vaccines

Vaccine Devices & Delivery

Human Vaccine Markets

1 Human Injection Flu Vaccine Market Overview
1.1 Product Definition
1.2 Human Injection Flu Vaccine by Type
1.2.1 Global Human Injection Flu Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Human Injection Flu Vaccine by Application
1.3.1 Global Human Injection Flu Vaccine Market Value by Application (2024 VS 2031)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Human Injection Flu Vaccine Market Size Estimates and Forecasts
1.4.1 Global Human Injection Flu Vaccine Revenue 2020-2031
1.4.2 Global Human Injection Flu Vaccine Sales 2020-2031
1.4.3 Global Human Injection Flu Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Injection Flu Vaccine Market Competition by Manufacturers
2.1 Global Human Injection Flu Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Injection Flu Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Injection Flu Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Injection Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Injection Flu Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Injection Flu Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Human Injection Flu Vaccine, Date of Enter into This Industry
2.8 Global Human Injection Flu Vaccine Market Competitive Situation and Trends
2.8.1 Global Human Injection Flu Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Injection Flu Vaccine Players Market Share by Revenue
2.8.3 Global Human Injection Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Injection Flu Vaccine Market Scenario by Region
3.1 Global Human Injection Flu Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Injection Flu Vaccine Sales by Region: 2020-2031
3.2.1 Global Human Injection Flu Vaccine Sales by Region: 2020-2025
3.2.2 Global Human Injection Flu Vaccine Sales by Region: 2026-2031
3.3 Global Human Injection Flu Vaccine Revenue by Region: 2020-2031
3.3.1 Global Human Injection Flu Vaccine Revenue by Region: 2020-2025
3.3.2 Global Human Injection Flu Vaccine Revenue by Region: 2026-2031
3.4 North America Human Injection Flu Vaccine Market Facts & Figures by Country
3.4.1 North America Human Injection Flu Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Injection Flu Vaccine Sales by Country (2020-2031)
3.4.3 North America Human Injection Flu Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Injection Flu Vaccine Market Facts & Figures by Country
3.5.1 Europe Human Injection Flu Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Injection Flu Vaccine Sales by Country (2020-2031)
3.5.3 Europe Human Injection Flu Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Injection Flu Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Human Injection Flu Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Injection Flu Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Injection Flu Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Injection Flu Vaccine Market Facts & Figures by Country
3.7.1 Latin America Human Injection Flu Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Injection Flu Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Human Injection Flu Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Injection Flu Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Injection Flu Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Injection Flu Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Injection Flu Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Injection Flu Vaccine Sales by Type (2020-2031)
4.1.1 Global Human Injection Flu Vaccine Sales by Type (2020-2025)
4.1.2 Global Human Injection Flu Vaccine Sales by Type (2026-2031)
4.1.3 Global Human Injection Flu Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Human Injection Flu Vaccine Revenue by Type (2020-2031)
4.2.1 Global Human Injection Flu Vaccine Revenue by Type (2020-2025)
4.2.2 Global Human Injection Flu Vaccine Revenue by Type (2026-2031)
4.2.3 Global Human Injection Flu Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Human Injection Flu Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Injection Flu Vaccine Sales by Application (2020-2031)
5.1.1 Global Human Injection Flu Vaccine Sales by Application (2020-2025)
5.1.2 Global Human Injection Flu Vaccine Sales by Application (2026-2031)
5.1.3 Global Human Injection Flu Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Human Injection Flu Vaccine Revenue by Application (2020-2031)
5.2.1 Global Human Injection Flu Vaccine Revenue by Application (2020-2025)
5.2.2 Global Human Injection Flu Vaccine Revenue by Application (2026-2031)
5.2.3 Global Human Injection Flu Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Human Injection Flu Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Human Injection Flu Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Human Injection Flu Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Human Injection Flu Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viatris Human Injection Flu Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AstraZeneca Human Injection Flu Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Company Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hualan Bio Human Injection Flu Vaccine Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.7.1 Changchun Institute of Biological Company Information
6.7.2 Changchun Institute of Biological Description and Business Overview
6.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Changchun Institute of Biological Human Injection Flu Vaccine Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Company Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sinovac Human Injection Flu Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 Jiangsu GDK
6.9.1 Jiangsu GDK Company Information
6.9.2 Jiangsu GDK Description and Business Overview
6.9.3 Jiangsu GDK Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Jiangsu GDK Human Injection Flu Vaccine Product Portfolio
6.9.5 Jiangsu GDK Recent Developments/Updates
6.10 KM Biologics
6.10.1 KM Biologics Company Information
6.10.2 KM Biologics Description and Business Overview
6.10.3 KM Biologics Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 KM Biologics Human Injection Flu Vaccine Product Portfolio
6.10.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Injection Flu Vaccine Industry Chain Analysis
7.2 Human Injection Flu Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Injection Flu Vaccine Production Mode & Process Analysis
7.4 Human Injection Flu Vaccine Sales and Marketing
7.4.1 Human Injection Flu Vaccine Sales Channels
7.4.2 Human Injection Flu Vaccine Distributors
7.5 Human Injection Flu Vaccine Customer Analysis
8 Human Injection Flu Vaccine Market Dynamics
8.1 Human Injection Flu Vaccine Industry Trends
8.2 Human Injection Flu Vaccine Market Drivers
8.3 Human Injection Flu Vaccine Market Challenges
8.4 Human Injection Flu Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
CSL Limited
GSK
Viatris
Astrazeneca plc
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
List of Tables
 Table 1. Global Human Injection Flu Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Injection Flu Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Injection Flu Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Injection Flu Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Human Injection Flu Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Injection Flu Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Injection Flu Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Injection Flu Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Injection Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Injection Flu Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Injection Flu Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Human Injection Flu Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Injection Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Injection Flu Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Injection Flu Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Injection Flu Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Human Injection Flu Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Human Injection Flu Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Human Injection Flu Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Human Injection Flu Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Injection Flu Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Injection Flu Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Injection Flu Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Injection Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Injection Flu Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Human Injection Flu Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Human Injection Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Injection Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Injection Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Injection Flu Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Human Injection Flu Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Human Injection Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Injection Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Injection Flu Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Injection Flu Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Human Injection Flu Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Human Injection Flu Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Injection Flu Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Injection Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Injection Flu Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Human Injection Flu Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Human Injection Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Injection Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Injection Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Injection Flu Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Human Injection Flu Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Human Injection Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Injection Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Injection Flu Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Human Injection Flu Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Human Injection Flu Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Human Injection Flu Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Human Injection Flu Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Injection Flu Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Injection Flu Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Injection Flu Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Injection Flu Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Human Injection Flu Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Human Injection Flu Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Human Injection Flu Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Human Injection Flu Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Human Injection Flu Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Human Injection Flu Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Injection Flu Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Injection Flu Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Injection Flu Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Injection Flu Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Human Injection Flu Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Human Injection Flu Vaccine Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. CSL Company Information
 Table 76. CSL Description and Business Overview
 Table 77. CSL Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. CSL Human Injection Flu Vaccine Product
 Table 79. CSL Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GSK Human Injection Flu Vaccine Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Viatris Company Information
 Table 86. Viatris Description and Business Overview
 Table 87. Viatris Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Viatris Human Injection Flu Vaccine Product
 Table 89. Viatris Recent Developments/Updates
 Table 90. AstraZeneca Company Information
 Table 91. AstraZeneca Description and Business Overview
 Table 92. AstraZeneca Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. AstraZeneca Human Injection Flu Vaccine Product
 Table 94. AstraZeneca Recent Developments/Updates
 Table 95. Hualan Bio Company Information
 Table 96. Hualan Bio Description and Business Overview
 Table 97. Hualan Bio Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Hualan Bio Human Injection Flu Vaccine Product
 Table 99. Hualan Bio Recent Developments/Updates
 Table 100. Changchun Institute of Biological Company Information
 Table 101. Changchun Institute of Biological Description and Business Overview
 Table 102. Changchun Institute of Biological Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Changchun Institute of Biological Human Injection Flu Vaccine Product
 Table 104. Changchun Institute of Biological Recent Developments/Updates
 Table 105. Sinovac Company Information
 Table 106. Sinovac Description and Business Overview
 Table 107. Sinovac Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sinovac Human Injection Flu Vaccine Product
 Table 109. Sinovac Recent Developments/Updates
 Table 110. Jiangsu GDK Company Information
 Table 111. Jiangsu GDK Description and Business Overview
 Table 112. Jiangsu GDK Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Jiangsu GDK Human Injection Flu Vaccine Product
 Table 114. Jiangsu GDK Recent Developments/Updates
 Table 115. KM Biologics Company Information
 Table 116. KM Biologics Description and Business Overview
 Table 117. KM Biologics Human Injection Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. KM Biologics Human Injection Flu Vaccine Product
 Table 119. KM Biologics Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Human Injection Flu Vaccine Distributors List
 Table 123. Human Injection Flu Vaccine Customers List
 Table 124. Human Injection Flu Vaccine Market Trends
 Table 125. Human Injection Flu Vaccine Market Drivers
 Table 126. Human Injection Flu Vaccine Market Challenges
 Table 127. Human Injection Flu Vaccine Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Injection Flu Vaccine
 Figure 2. Global Human Injection Flu Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Injection Flu Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Trivalent Influenza Vaccine Product Picture
 Figure 5. Quadrivalent Influenza Vaccine Product Picture
 Figure 6. Global Human Injection Flu Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Human Injection Flu Vaccine Market Share by Application: 2024 & 2031
 Figure 8. 6 Months to 3 Years
 Figure 9. > 3 Years
 Figure 10. Global Human Injection Flu Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Human Injection Flu Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Human Injection Flu Vaccine Sales (2020-2031) & (K Units)
 Figure 13. Global Human Injection Flu Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Human Injection Flu Vaccine Report Years Considered
 Figure 15. Human Injection Flu Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Human Injection Flu Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Human Injection Flu Vaccine Players: Market Share by Revenue in Human Injection Flu Vaccine in 2024
 Figure 18. Human Injection Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Human Injection Flu Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Human Injection Flu Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Human Injection Flu Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Human Injection Flu Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Human Injection Flu Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Human Injection Flu Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Human Injection Flu Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Human Injection Flu Vaccine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Human Injection Flu Vaccine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Human Injection Flu Vaccine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Human Injection Flu Vaccine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Human Injection Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Human Injection Flu Vaccine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Human Injection Flu Vaccine by Type (2020-2031)
 Figure 55. Global Human Injection Flu Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Human Injection Flu Vaccine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Human Injection Flu Vaccine by Application (2020-2031)
 Figure 58. Global Human Injection Flu Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 59. Human Injection Flu Vaccine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Injection Influenza Vaccine Market Research Report 2025
Global Injection Flu Shot Market Research Report 2025
Global Flu Vaccination Market Research Report 2025
Global Flu Vaccine Market Insights Forecast to 2030
Children Influenza Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Flu RNA Vaccines Market Research Report 2025
Global Influenza Subunit Vaccine Market Research Report 2024
Global Influenza Therapeutics Market Insights Forecast to 2030
Global Adjuvanted Influenza Vaccine Market Research Report 2024
Global Egg Based Flu Vaccines Market Research Report 2024
Global Flu Prevention Market Research Report 2024
Global Anti Influenza Virus Chinese Medicine Market Research Report 2024
Global Egg free Flu Vaccine Market Research Report 2024
Global Recombinant Influenza Vaccine Market Research Report 2024
Global Paediatric Influenza Prevention Market Research Report 2024
Influenza Virus Vaccine H1N1 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine for Influenza Market Research Report 2025
Global Viral Vector Vaccine for Humans Market Research Report 2024
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Avian Influenza Vaccines Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions